Breast Imaging Section Passes FDA Inspection With Flying Colors

Posted on February 2013

The UWHC Breast Imaging Section completed the annual 2013 FDA/MQSA Inspection in January, and we are pleased to announce the section passed with flying colors. This glowing review can be attributed to all of the Breast Imaging staff on their outstanding quality control documentation. The section’s patient satisfaction scores also show their outstanding ability to provide excellent patient care. Their innovation in developing and streamlining the QC books was lauded by the FDA/MQSA inspector multiple times during the exit interview.

This annual inspection is conducted by the U.S. Department of Health and Human Services Food and Drug Administration (FDA) and required by the Mammography Quality Standards Act (MQSA), established in 1994 by the United States Congress. The accreditation program focuses on six major areas including facility equipment performance, technologist quality control, medical physicist survey, technologist and radiologist personal qualification, medical reports, and outcome audits.

A special thanks to Dr. Roberta Strigel, quality control radiologist; Tamela Jorgensen, lead technologist; and John Vetter from the Department of Medical Physics for monitoring such an outstanding program.